Blank D L
Pharmacol Biochem Behav. 1976 Apr;4(4):485-7. doi: 10.1016/0091-3057(76)90069-1.
Recent evidence has suggested that electroshock seizure threshold is correlated with levels of brain biogenic amines. Reserpine, a drug that depletes serotonin and norepinephrine, has been shown to decrease seizure thresholds. ECS treatment has been shown to increase amine levels as well as seizure thresholds. Combined reserpine and ECS have been shown to produce an intermediate level of serotonin and norepinephrine, but seizure threshold data for this group is absent. It was the purpose of this study to examine the seizure thresholds for combined treatment and compare them with groups treated with reserpine alone, ECS alone, and a placebo control group. The results suggest that, if only maximal seizures are considered, the seizure threshold is lowest for the reserpine and highest for the ECS alone or control groups, with the combined treatment group falling intermediate. If both minimal and maximal seizures are considered, the reserpine and combined treatment groups do not differ from one another, but do show a lower threshold as compared to ECS or control groups.
最近的证据表明,电击惊厥阈值与脑内生物胺水平相关。利血平是一种能消耗血清素和去甲肾上腺素的药物,已被证明会降低惊厥阈值。电休克治疗(ECS)已被证明能提高胺水平以及惊厥阈值。利血平和ECS联合使用已被证明能产生中等水平的血清素和去甲肾上腺素,但该组的惊厥阈值数据缺失。本研究的目的是检查联合治疗的惊厥阈值,并将其与单独使用利血平、单独使用ECS以及安慰剂对照组进行比较。结果表明,如果仅考虑最大惊厥,利血平组的惊厥阈值最低,单独使用ECS组或对照组的惊厥阈值最高,联合治疗组则介于两者之间。如果同时考虑最小和最大惊厥,利血平组和联合治疗组之间没有差异,但与ECS组或对照组相比,惊厥阈值较低。